IRIS
MISSALE, Gabriele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.175
EU - Europa 2.826
AS - Asia 1.490
AF - Africa 40
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 5
Totale 7.545
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.147
CN - Cina 898
IE - Irlanda 824
SE - Svezia 648
IT - Italia 576
SG - Singapore 372
DE - Germania 222
FR - Francia 167
FI - Finlandia 164
TR - Turchia 160
UA - Ucraina 62
AT - Austria 38
CI - Costa d'Avorio 38
BE - Belgio 26
CA - Canada 24
GB - Regno Unito 22
IN - India 21
NL - Olanda 19
CZ - Repubblica Ceca 16
RO - Romania 10
HK - Hong Kong 7
BR - Brasile 6
DK - Danimarca 6
ES - Italia 5
EU - Europa 5
JP - Giappone 5
CH - Svizzera 4
IR - Iran 4
MX - Messico 4
RU - Federazione Russa 4
IL - Israele 3
LU - Lussemburgo 3
QA - Qatar 3
TH - Thailandia 3
TW - Taiwan 3
BD - Bangladesh 2
CO - Colombia 2
GR - Grecia 2
KH - Cambogia 2
KZ - Kazakistan 2
PK - Pakistan 2
SI - Slovenia 2
AE - Emirati Arabi Uniti 1
BO - Bolivia 1
EE - Estonia 1
ET - Etiopia 1
HR - Croazia 1
MK - Macedonia 1
OM - Oman 1
PH - Filippine 1
PL - Polonia 1
PT - Portogallo 1
RS - Serbia 1
ZA - Sudafrica 1
Totale 7.545
Salva come PNG Salva come JPEG
Città #
Dublin 824
Chandler 620
Singapore 252
Ashburn 250
Boardman 212
Ann Arbor 201
Beijing 194
Dearborn 191
Parma 163
Shanghai 154
Princeton 147
Izmir 130
Nanjing 116
New York 108
Wilmington 99
Grafing 77
Jacksonville 69
Helsinki 65
Milan 55
Jinan 51
Shenyang 49
Des Moines 47
Bremen 43
Santa Clara 42
Abidjan 38
Vienna 38
Seattle 33
Hebei 32
Kocaeli 30
Kunming 30
Tianjin 27
Nanchang 26
Hefei 24
Redmond 23
Ardea 22
Los Angeles 22
Rome 22
Chicago 21
Jiaxing 20
Guangzhou 19
Brussels 18
Munich 18
Norwalk 18
San Mateo 18
Bologna 17
Changsha 15
Fairfield 15
Fremont 15
Woodbridge 15
Falls Church 13
Hangzhou 12
Toronto 12
Düsseldorf 11
Marseille 11
Montespertoli 11
Zhengzhou 11
Brno 10
Casalecchio di Reno 10
Dallas 10
Limena 9
Reggio Emilia 9
Mestre 8
Pune 8
Rockville 8
Modena 7
Terni 7
Borås 6
Brooklyn 6
Houston 6
Rio de Janeiro 6
Taastrup 6
Taiyuan 6
Washington 6
West Jordan 6
Binasco 5
Chengdu 5
Council Bluffs 5
Focsani 5
Haikou 5
Montreal 5
Ningbo 5
Bordeaux 4
Central 4
Fuzhou 4
Lausanne 4
London 4
Manchester 4
Piacenza 4
Redwood City 4
Rio Saliceto 4
Springfield 4
Stockholm 4
Vittuone 4
Waanrode 4
Wayne 4
Augusta 3
Bangkok 3
Cento 3
Cortemaggiore 3
Doha 3
Totale 5.056
Salva come PNG Salva come JPEG
Nome #
Role of immunoglobulin G fragment C receptor polymorphism-mediatedantibody-dependant1. cellular cytotoxicity in colorectal cancer treated withcetuximab therapy. Pharmacogenomics J. 166
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection 128
The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC 115
Ammonium Production and Glutamine-Addiction of Myeloma Cells: New Attractive Targets in Multiple Myeloma 101
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target 101
A novel enhancing effect of SARS-CoV-2 mutations on anti-viral CD8 T cell responses 93
Metabolic regulation of the HBV-specific T cell function 83
Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B 83
Cytotoxic T Cell response to Melanoma Associated Antigens (MAGE) in patients with Hepatocellular Carcinoma 79
L-Asparaginase and Inhibitors of Glutamine Synthetase DiscloseGlutamine Addiction of Beta-Catenin-Mutated Human HepatocellularCarcinoma Cells 78
Resolution of late-onset heart and liver failures after reversion of jejuno-ileal bypass: a case report 78
Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B 78
Glutamine depletion by crisantaspase hinders the growth of human hepatocellular carcinoma xenografts 76
Clinico-Immunological Profile of a 67-Year-Old Woman Affected by HER2-Positive Breast Cancer and Autoimmune Dermatomyositis 76
Soluble PD-L1 and Circulating CD8+PD-1+ and NK Cells Enclose a Prognostic and Predictive Immune Effector Score in Immunotherapy Treated NSCLC patients 75
A simplified sars-cov-2 pseudovirus neutralization assay 75
DEPENDENCE ON GLUTAMINE UPTAKE OF MYELOMA CELLS DELINEATES A NEW ATTRACTIVE THERAPEUTIC STRATEGY 74
Ex vivo characterization of tumor-derived melanoma antigenencoding gene-specific CD8 1 cells in patientswith hepatocellular carcinoma 73
CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells 72
Immune gene expression profile in hepatocellular carcinoma and surrounding tissue predicts time to tumor recurrence 69
Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment. 69
Antibody responses to hepatitis C virus hypervariable region 1: evidence for cross-reactivity and immune-mediated sequence variation 68
Are Anti-TNF-α Agents Safe for Treating Psoriasis in Hepatitis C Virus Patients with Advanced Liver Disease? Case Reports and Review of the Literature 68
Energy metabolism and cell motility defect in NK-cells from patients with hepatocellular carcinoma 68
Circulating immune-profile as predictor of outcome in advanced NSCLC patients treated with Nivolumab 67
FUNCTIONAL AND TRANSCRIPTIONAL RESTORATION OF EXHAUSTED VIRUS-SPECIFIC T LYMPHOCYTES FROM PATIENTS WITH CHRONIC HEPATITIS B 65
T cell regulation in HBV-related chronic liver disease 65
Activation of Natural Killer Cells During Acute Infection With Hepatitis C Virus 64
Clinical and hematologic parameters address the outcomes of non-small-cell lung cancer patients treated with nivolumab 64
Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection 63
Anti-Viral Intrahepatic T-Cell Responses can be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B 63
Simultaneous Combination of the CDK4/6 Inhibitor Palbociclib With Regorafenib Induces Enhanced Anti-tumor Effects in Hepatocarcinoma Cell Lines 62
Changes in hepatocellular carcinoma aggressiveness characteristics with an increase in tumor diameter 62
Neoplastic macrovascular invasion represents an independent risk factor for dismal survival in sorafenib treatment for hepatocellular carcinoma 60
Role of innate and adaptive immunity in the efficacy of anti-HER2 monoclonal antibodies for HER2-positive breast cancer 60
Vascular liver injury mimicking an intrahepatic cholangiocarcinoma in a COVID-19 patient 60
Antiviral CD8-mediated responses in chronic HCV carriers with HBV superinfection 59
Impact of Soluble CD26 on Treatment Outcome and Hepatitis C Virus-Specific T Cells in Chronic Hepatitis C Virus Genotype 1 Infection 58
HBV immune-therapy: From molecular mechanisms to clinical applications 58
[68Ga]Nivolumab: a novel PET tracer to detect PD-1 expressing tumors 58
Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV 58
Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu-Positive Metastatic Breast Cancer. 57
The Characteristics of the Cell-Mediated Immune Response Identify Different Profiles of Occult Hepatitis B Virus Infection 55
Role of immunoglobulin G fragment C receptor polymorphism-mediated antibody-dependant cellular cytotoxicity in colorectal cancer treated with cetuximab therapy 54
The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort study 54
Etanercept in the treatment of psoriasis and psoriathic arthritis with concomitant hepatitis C virus infection: clinical and virological study in three patients 54
Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutations 53
Oral lichen planus pathogenesis: A role for the HCV-specific cellular immune response. 53
Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein 53
Role of viral and host factors in HCV persistence: Which lesson for therapeutic and preventive strategies? 52
Fine specificity of the human T cell response to hepatitis B virus core antigen 52
Antibody responses to hepatitis C virus hypervariable region 1: Evidence for cross-reactivity and immune-mediated sequence variation 52
Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic Approaches 52
IMMUNE ESCAPE OF HEPATIC AND GASTROINTESTINAL CANCER:SECRETION OF SOLUBLE COMPLEMENT INHIBITORS 52
Oral lichen planus infiltrating T-cells:a Pathogenetic role for HCV-specific T cell responses? 51
Immune pathogenesis of hepatitis B 51
Radiofrequency Thermal Ablation for Hepatocellular Carcinoma Stimulates Autologous NK-Cell Response 51
Expression of pERK and VEGFR-2 in advanced hepatocellular carcinoma and resistance to sorafenib treatment 50
Parenteral exposure to high HIV viremia leads to virus-specific T cell priming without evidence of infection 50
Natural killer cells phenotypic characterization as an outcome predictor of HCV-linked HCC after curative treatments 49
Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B 48
Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses 47
The good and the bad of natural killer cells in virus control: Perspective for anti-HBV therapy 47
Head-injured subjects aged over 50 years: correlations between variables of trauma and neuropsychologial follow-up 47
AISF position paper on HCV in immunocompromised patients 47
Integrated prognostication of intrahepatic cholangiocarcinoma by contrast-enhanced computed tomography: the adjunct yield of radiomics 47
TRANSCRIPTOME ANALYSIS OF EXHAUSTED VIRUS-SPECIFIC CD8 T CELLS IN CHRONIC HBV INFECTION IDENTIFIES PROFOUND METABOLIC AND FUNCTIONAL CELL DEFECTS 47
Intratumor Regulatory Noncytotoxic NK Cells in Patients with Hepatocellular Carcinoma 47
Cytotoxic T Cell response to Melanoma Associated Antigens (MAGE) in patients with Hepatocellular Carcinoma. 46
Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection 45
Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues 45
Early kinetics of innate and adaptive immune responses during hepatitis B virus infection 44
Immunological and molecular correlates of disease recurrence after liver resection for hepatocellular carcinoma. 44
Immunoglobulin G fragment C receptor polymorphisms and response to trastuzumab-based treatment in patients with HER-2/NEU-positive metastatic breast cancer 44
Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen 44
Lack of full CD8 functional restoration after antiviral treatment for acute and chronic hepatitis C virus infection 44
High ASCT2 activity as a marker of extracellular glutamine dependence in ammoniagenic multiple myeloma cell lines 43
Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection 43
The changing scenario of hepatocellular carcinoma in Italy: an update 43
Unraveling the multifaceted nature of cd8 t cell exhaustion provides the molecular basis for therapeutic t cell reconstitution in chronic hepatitis b and c 43
Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study Group 42
Circulating immune-profile as predictor of outcome in NSCLC patients treated with nivolumab 42
Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C 41
The evolutionary scenario of hepatocellular carcinoma in Italy: an update 41
Application of the Intermediate-Stage Subclassification to Patients with Untreated Hepatocellular Carcinoma 40
Conserved hepatitis C virus sequences are highly immunogenic for CD4+ T cells: Implications for vaccine development 40
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response 40
Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses 40
IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection 39
Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B 38
COMPOSTO E COMPOSIZIONE PER IL RIPRISTINO METABOLICO E FUNZIONALE DEI LINFOCITI NK NELL’EPATOCARCINOMA E RELATIVO METODO 38
PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion 38
Infection of circulating and liver infiltrating T cells by hepatitis C virus of different subtypes 38
Rifaximin versus neomycin on hyperammoniemia in chronic portal systemic encephalopathy of cirrhotics. A double-blind, randomized trial 38
Comparative pathogenesis of HBV and HCV 37
Metabolic disorders across hepatocellular carcinoma in Italy 37
T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections 37
Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma 37
The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro 37
Increased immunostimulatory activity conferred to antigen-presenting cells by exposure to antigen extract from hepatocellular carcinoma after radiofrequency thermal ablation 36
Totale 5.768
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.399
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.399
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020767 0 0 0 22 56 198 116 53 109 139 55 19
2020/2021627 19 28 20 9 51 53 72 72 144 70 54 35
2021/2022727 19 21 26 53 47 91 38 54 36 21 44 277
2022/20232.802 318 250 185 172 168 298 53 157 988 25 116 72
2023/20241.260 72 122 42 57 113 292 85 88 46 74 92 177
2024/2025671 91 221 279 80 0 0 0 0 0 0 0 0
Totale 7.818